C4 Therapeutics, Inc. · NASDAQ:CCCC
C4 Therapeutics, Inc. shareholders
As of Jun 30, 2026, 142 institutions reported holding C4 Therapeutics, Inc., 95.6% of its shares. Largest: Morgan Stanley, Ra Capital Management, L.P. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of C4 Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Morgan Stanley | 8.87M | 7.2% | −205K | Aug 13, 2026 |
| Ra Capital Management, L.P. | 8M | 6.5% | no change | Aug 14, 2026 |
| BlackRock | 7.9M | 6.4% | +5.85M | Aug 7, 2026 |
| Lynx1 Capital Management LP | 7.33M | 6.0% | +328K | Aug 13, 2026 |
| Squadron Capital Management LLC | 7.2M | 5.9% | +4.95M | Aug 14, 2026 |
| Bain Capital Life Sciences Investors, LLC | 7.17M | 5.8% | no change | Aug 14, 2026 |
| Vanguard | 5.76M | 4.7% | +1.36M | Aug 13, 2026 |
| JPMorgan | 4.75M | 3.9% | +1.52M | Aug 12, 2026 |
| Citadel | 4.19M | 3.4% | +1.68M | Aug 14, 2026 |
| Goldman Sachs | 3.53M | 2.9% | +1.14M | Aug 14, 2026 |